Contemporary Issues in Lung CancerJones & Bartlett Publishers, 2009 M02 12 - 364 pages In the United States, lung cancer is the second most commonly diagnosed cancer and the leading cause of cancer death. Even more devastating is its five-year survival rate of only 15.8%. Despite these dismal facts, lung cancer receives little national attention and research and funding for lung cancer lags behind other cancers. The intent of Contemporary Issues in Lung Cancer: A Nursing Perspective Second Edition is to provide oncology nurses and healthcare professionals with in-depth information on the issues that surround this disease, so that they might impact both education and research and provide better care for their patients. |
From inside the book
Results 1-5 of 91
Page 5
... Stage. Epidemiology. of. Lung. Cancer. In the United States, lung cancer is the second most common cancer diagnosed in men and women today (Jemal, et al., 2008). The American Cancer Society estimates there will be 215,020 new cases of lung ...
... Stage. Epidemiology. of. Lung. Cancer. In the United States, lung cancer is the second most common cancer diagnosed in men and women today (Jemal, et al., 2008). The American Cancer Society estimates there will be 215,020 new cases of lung ...
Page 6
... Stage Distribution at Lung Cancer Diagnosis Time at. Source: SEER, data 2001–2005. Types of Lung Cancer Lung cancers arise from abnormal epithelial cells in the airways of the lung. The World Health Organization (WHO) divides lung can ...
... Stage Distribution at Lung Cancer Diagnosis Time at. Source: SEER, data 2001–2005. Types of Lung Cancer Lung cancers arise from abnormal epithelial cells in the airways of the lung. The World Health Organization (WHO) divides lung can ...
Page 7
... stage disease, whereas squamoid tumors are associated with increased sur- vival in advanced disease. SCLC is in a separate category because of its rapid proliferation, high growth fraction, and the early development of widespread ...
... stage disease, whereas squamoid tumors are associated with increased sur- vival in advanced disease. SCLC is in a separate category because of its rapid proliferation, high growth fraction, and the early development of widespread ...
Page 8
... stage I tumors were further subdivided into IA and IB. Survival difference based on this distinction has been noted in clinical trial analyses. Stage II disease was similarly divided into stage IIA and IIB. Again, A and B were divided ...
... stage I tumors were further subdivided into IA and IB. Survival difference based on this distinction has been noted in clinical trial analyses. Stage II disease was similarly divided into stage IIA and IIB. Again, A and B were divided ...
Page 9
... Illinois. The original source for this material is the AJCC Cancer Staging Manual, 6th edition (2002) published by Lippincott-Raven, Philadelphia, Pennsylvania. Table 1–6 Stage Grouping Stage grouping of the TNM subsets Risk Factors 9.
... Illinois. The original source for this material is the AJCC Cancer Staging Manual, 6th edition (2002) published by Lippincott-Raven, Philadelphia, Pennsylvania. Table 1–6 Stage Grouping Stage grouping of the TNM subsets Risk Factors 9.
Contents
Oncology Treatment Modalities | 45 |
Special Issues Facing Individuals with Lung Cancer | 117 |
Psychosocial Issues of Individuals with Lung Cancer | 231 |
Assistance and Resources for Individuals Facing Lung Cancer | 255 |
Media and Future Research Directions | 301 |
Index | 353 |
Other editions - View all
Common terms and phrases
adjuvant agents aprepitant associated bevacizumab breathing breathlessness Bruera carboplatin carcinoma cell lung cancer chemotherapy chronic cisplatin Clinical Oncology clinical trials combination diagnosis disease docetaxel dose drug dyspnea EGFR erlotinib etoposide evaluation evidence-based factors fatigue gefitinib gemcitabine gene improve increased individuals indoor radon Internet intervention irinotecan Journal of Clinical lung cancer patients Medicine ment metastatic months NCCN nicotine non-small cell lung NSCLC Nursing Forum Oncology Nursing Oncology Nursing Forum paclitaxel palliative palliative care patient navigation patients and families patients with lung pemetrexed phase potential pulmonary quit smoking radiation therapy radiotherapy radon randomized receptors regimen reported resection respiratory response rate risk role SCLC score screening Sekido side effects small cell lung smoking cessation stage strategies support group surgical survival rate Symptom Management Table tients tion tobacco topotecan toxicity treat treatment tumor versus vinorelbine weight loss